Angiopoietin 2 Stimulates TIE2-Expressing Monocytes To Suppress T Cell Activation and To Promote Regulatory T Cell Expansion
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Angiopoietin 2 (ANGPT2) is a proangiogenic cytokine whose expression is often upregulated by endothelial cells in tumors. Expression of its receptor, TIE2, defines a highly proangiogenic subpopulation of myeloid cells in circulation and tumors called TIE2-expressing monocytes/macrophages (TEMs). Genetic depletion of TEMs markedly reduces tumor angiogenesis in various tumor models, emphasizing their essential role in driving tumor progression. Previously, we demonstrated that ANGPT2 augments the expression of various proangiogenic genes, the potent immunosuppressive cytokine, IL-10, and a chemokine for regulatory T cells (Tregs), CCL17 by TEMs in vitro. We now show that TEMs also express higher levels of IL-10 than TIE2− macrophages in tumors and that ANGPT2-stimulated release of IL-10 by TEMs suppresses T cell proliferation, increases the ratio of CD4+ T cells to CD8+ T cells, and promotes the expansion of CD4+CD25highFOXP3+ Tregs. Furthermore, syngeneic murine tumors expressing high levels of ANGPT2 contained not only high numbers of TEMs but also increased numbers of Tregs, whereas genetic depletion of tumor TEMs resulted in a marked reduction in the frequency of Tregs in tumors. Taken together, our data suggest that ANGPT2-stimulated TEMs represent a novel, potent immunosuppressive force in tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“First, ANG2 increases leukocyte–endothelial interactions via upregulation of adhesion molecules, thereby facilitating the recruitment of MDSCs29, Treg cells30, and TIE2-expressing monocytes that induce immunosuppression31”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [30]
In the citing paper
“Thirdly, despite without direct influence on T cells, ANGPT2 recruits Tie-2-expressing monocytes, enhances the differentiation towards M2-like macrophages, and upregulates the expression of IL-10 [94–97].”
From Combination strategies with PD-1/PD-L1 blockade: current advances and future directions (2022) · cites this paper as [96]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287
Stein, M., Keshav, S., Harris, N., & Gordon, S. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.287 · Cited by 1,960 · cited 1×
“IFN-g and IL-4 were used as controls in coculture assays as they induce an M1/immunostimulatory and M2/immunosuppressive phenotype in monocytes, respectively (9, 10, 16).”
MethodControl of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Augustin, H. G., Young Koh, G., Thurston, G., & Alitalo, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,465
Huang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435
De Palma, M., Venneri, M. A., Galli, R., Sergi, L. S., Politi, L. S., Sampaolesi, M., & Naldini, L. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.002 · Cited by 1,311
Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276
Movahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stangé, G., Van den Bossche, J., Mack, M., Pipeleers, D., In't Veld, P., De Baetselier, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,239
Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P., & Van Ginderachter, J. A. (2008) · Blood · doi:10.1182/blood-2007-07-099226 · Cited by 1,234
The Terminology Issue for Myeloid-Derived Suppressor Cells
Gabrilovich, D. I., Bronte, V., Chen, S.-H., Colombo, M. P., Ochoa, A., Ostrand-Rosenberg, S., & Schreiber, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3037 · Cited by 835
Cited by
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Fukumura, D., Kloepper, J., Amoozgar, Z., Duda, D. G., & Jain, R. K. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.29 · Cited by 2,027
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
Yi, M., Zheng, X., Niu, M., Zhu, S., Ge, H., & Wu, K. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01489-2 · Cited by 1,445
T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
Facciabene, A., Motz, G. T., & Coukos, G. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3687 · Cited by 821
The three human monocyte subsets: implications for health and disease
Wong, K. L., Yeap, W. H., Tai, J. J. Y., Ong, S. M., Dang, T. M., & Wong, S. C. (2012) · Immunologic Research · doi:10.1007/s12026-012-8297-3 · Cited by 680
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
Khan, K. A., & Kerbel, R. S. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.9 · Cited by 657
Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
Riabov, V., Gudima, A., Wang, N., Mickley, A., Orekhov, A., & Kzhyshkowska, J. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00075 · Cited by 628
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
Tay, C., Tanaka, A., & Sakaguchi, S. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.014 · Cited by 580
Deciphering and Reversing Tumor Immune Suppression
Motz, G. T., & Coukos, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.005 · Cited by 598
Monocyte heterogeneity and functions in cancer
Olingy, C. E., Dinh, H. Q., & Hedrick, C. C. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ri0818-311r · Cited by 579
Schmittnaegel, M., Rigamonti, N., Kadioglu, E., Cassará, A., Wyser Rmili, C., Kiialainen, A., Kienast, Y., Mueller, H.-J., Ooi, C.-H., Laoui, D., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aak9670 · Cited by 582
The Intersection between Tumor Angiogenesis and Immune Suppression
Rahma, O. E., & Hodi, F. S. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1543 · Cited by 472
The roles of tumor-associated macrophages in tumor angiogenesis and metastasis
Fu, L.-Q., Du, W.-L., Cai, M.-H., Yao, J.-Y., Zhao, Y.-Y., & Mou, X.-Z. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104119 · Cited by 415
Kloepper, J., Riedemann, L., Amoozgar, Z., Seano, G., Susek, K., Yu, V., Dalvie, N., Amelung, R. L., Datta, M., Song, J. W., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525360113 · Cited by 357
Targeting angiogenesis in oncology, ophthalmology and beyond
Cao, Y., Langer, R., & Ferrara, N. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00671-z · Cited by 315
Kimura, T., Kato, Y., Ozawa, Y., Kodama, K., Ito, J., Ichikawa, K., Yamada, K., Hori, Y., Tabata, K., Takase, K., et al. (2018) · Cancer Science · doi:10.1111/cas.13806 · Cited by 336
Control of the Immune Response by Pro-Angiogenic Factors
Voron, T., Marcheteau, E., Pernot, S., Colussi, O., Tartour, E., Taieb, J., & Terme, M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00070 · Cited by 325
Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy
Riera-Domingo, C., Audigé, A., Granja, S., Cheng, W.-C., Ho, P.-C., Baltazar, F., Stockmann, C., & Mazzone, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00018.2019 · Cited by 310
Interplay between inflammation and cancer
(2020) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.09.004 · Cited by 290
Smith, B. D., Kaufman, M. D., Lu, W.-P., Gupta, A., Leary, C. B., Wise, S. C., Rutkoski, T. J., Ahn, Y. M., Al-Ani, G., Bulfer, S. L., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.006 · Cited by 279
Baer, C., Squadrito, M. L., Laoui, D., Thompson, D., Hansen, S. K., Kiialainen, A., Hoves, S., Ries, C. H., Ooi, C.-H., & De Palma, M. (2016) · Nature Cell Biology · doi:10.1038/ncb3371 · Cited by 259
The Multifaceted Role of Perivascular Macrophages in Tumors
Lewis, C. E., Harney, A. S., & Pollard, J. W. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.017 · Cited by 249
Self-citationAngiopoietin signaling in the vasculature
Eklund, L., & Saharinen, P. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.011 · Cited by 242
Angiopoietin‐2: a multifaceted cytokine that functions in both angiogenesis and inflammation
Scholz, A., Plate, K. H., & Reiss, Y. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12726 · Cited by 248
Self-citationAdipokines: masterminds of metabolic inflammation
Tilg, H., Ianiro, G., Gasbarrini, A., & Adolph, T. E. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01103-8 · Cited by 192
Neutrophils: important contributors to tumor progression and metastasis
Swierczak, A., Mouchemore, K. A., Hamilton, J. A., & Anderson, R. L. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9594-9 · Cited by 220
Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis
Holopainen, T., Saharinen, P., D’Amico, G., Lampinen, A., Eklund, L., Sormunen, R., Anisimov, A., Zarkada, G., Lohela, M., Heloterä, H., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs009 · Cited by 216
Myeloid WNT7b Mediates the Angiogenic Switch and Metastasis in Breast Cancer
Yeo, E.-J., Cassetta, L., Qian, B.-Z., Lewkowich, I., Li, J.-F., Stefater, J. A., Smith, A. N., Wiechmann, L. S., Wang, Y., Pollard, J. W., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2421 · Cited by 187
Molecular Insight of Regorafenib Treatment for Colorectal Cancer
Arai, H., Battaglin, F., Wang, J., Lo, J. H., Soni, S., Zhang, W., & Lenz, H.-J. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.101912 · Cited by 191
Hypoxia: The Cornerstone of Glioblastoma
Domènech, M., Hernández, A., Plaja, A., Martínez-Balibrea, E., & Balañà, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212608 · Cited by 173
The tumour microenvironment and immune milieu of cholangiocarcinoma
Fabris, L., Perugorria, M. J., Mertens, J., Björkström, N. K., Cramer, T., Lleo, A., Solinas, A., Sänger, H., Lukacs‐Kornek, V., Moncsek, A., et al. (2019) · Liver International · doi:10.1111/liv.14098 · Cited by 187
Bastman, J. J., Serracino, H. S., Zhu, Y., Koenig, M. R., Mateescu, V., Sams, S. B., Davies, K. D., Raeburn, C. D., McIntyre, R. C., Haugen, B. R., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4227 · Cited by 181
New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis
Larionova, I., Kazakova, E., Gerashchenko, T., & Kzhyshkowska, J. (2021) · Cancers · doi:10.3390/cancers13133253 · Cited by 166
Crane, C. A., Ahn, B. J., Han, S. J., & Parsa, A. T. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos014 · Cited by 169
Macrophage regulation of tumor angiogenesis: Implications for cancer therapy
Squadrito, M. L., & De Palma, M. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.04.005 · Cited by 170
Scholz, A., Harter, P. N., Cremer, S., Yalcin, B. H., Gurnik, S., Yamaji, M., Di Tacchio, M., Sommer, K., Baumgarten, P., Bähr, O., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505505 · Cited by 169
Self-citationHarney, A. S., Karagiannis, G. S., Pignatelli, J., Smith, B. D., Kadioglu, E., Wise, S. C., Hood, M. M., Kaufman, M. D., Leary, C. B., Lu, W.-P., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0241 · Cited by 161
Intertwined regulation of angiogenesis and immunity by myeloid cells
Rivera, L. B., & Bergers, G. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.005 · Cited by 158
Vascular Normalization: A New Window Opened for Cancer Therapies
Yang, T., Xiao, H., Liu, X., Wang, Z., Zhang, Q., Wei, N., & Guo, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.719836 · Cited by 141
Targeting tumor associated macrophages (TAMs) via nanocarriers
Singh, Y., Pawar, V. K., Meher, J. G., Raval, K., Kumar, A., Shrivastava, R., Bhadauria, S., & Chourasia, M. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.395 · Cited by 127
The irradiated tumor microenvironment: role of tumor-associated macrophages in vascular recovery
Russell, J. S., & Brown, J. M. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00157 · Cited by 131
Sidibe, A., Ropraz, P., Jemelin, S., Emre, Y., Poittevin, M., Pocard, M., Bradfield, P. F., & Imhof, B. A. (2018) · Nature Communications · doi:10.1038/s41467-017-02610-0 · Cited by 117
Maffei, R., Bulgarelli, J., Fiorcari, S., Bertoncelli, L., Martinelli, S., Guarnotta, C., Castelli, I., Deaglio, S., Debbia, G., De Biasi, S., et al. (2013) · Haematologica · doi:10.3324/haematol.2012.073080 · Cited by 116
Agonistic CD40 Antibodies in Cancer Treatment
Djureinovic, D., Wang, M., & Kluger, H. M. (2021) · Cancers · doi:10.3390/cancers13061302 · Cited by 120
Chen, L., Li, J., Wang, F., Dai, C., Wu, F., Liu, X., Li, T., Glauben, R., Zhang, Y., Nie, G., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1114 · Cited by 101
Innate effector cells in angiogenesis and lymphangiogenesis
Varricchi, G., Loffredo, S., Galdiero, M. R., Marone, G., Cristinziano, L., Granata, F., & Marone, G. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.05.002 · Cited by 116
Macrophage-tumor cell interactions regulate the function of nitric oxide
Rahat, M. A., & Hemmerlein, B. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00144 · Cited by 109
Crosstalk between angiogenesis and immune regulation in the tumor microenvironment
Kim, H. J., Ji, Y. R., & Lee, Y. M. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01389-z · Cited by 115
The emerging roles of macrophages in cancer metastasis and response to chemotherapy
Sanchez, L. R., Borriello, L., Entenberg, D. R., Condeelis, J. S., Oktay, M. H., & Karagiannis, G. S. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0218-056rr · Cited by 114
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia
Fiorcari, S., Maffei, R., Audrito, V., Martinelli, S., ten Hacken, E., Zucchini, P., Grisendi, G., Potenza, L., Luppi, M., Burger, J. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11782 · Cited by 114
Angiopoietin-2 TIEs Up Macrophages in Tumor Angiogenesis
De Palma, M., & Naldini, L. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0171 · Cited by 101
Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment
Mahlbacher, G. E., Curtis, L. T., Lowengrub, J. S., & Frieboes, H. B. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0313-7 · Cited by 112
Saeed, A., Park, R., & Sun, W. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01034-0 · Cited by 109
Tumor-associated macrophages: a short compendium
Prenen, H., & Mazzone, M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2997-3 · Cited by 108
The Wilms’ tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression
Wagner, K., Cherfils‐Vicini, J., Hosen, N., Hohenstein, P., Gilson, É., Hastie, N. D., Michiels, J., & Wagner, N. (2014) · Nature Communications · doi:10.1038/ncomms6852 · Cited by 104
Fiegle, E., Doleschel, D., Koletnik, S., Rix, A., Weiskirchen, R., Borkham‐Kamphorst, E., Kiessling, F. M., & Lederle, W. (2019) · Neoplasia · doi:10.1016/j.neo.2019.07.006 · Cited by 106
Lohela, M., Casbon, A.-J., Olow, A., Bonham, L., Branstetter, D., Weng, N., Smith, J., & Werb, Z. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419899111 · Cited by 95
Leong, A., & Kim, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228689 · Cited by 102
Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs)
Sica, A., Porta, C., Morlacchi, S., Banfi, S., Strauss, L., Rimoldi, M., Totaro, M. G., & Riboldi, E. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0091-6 · Cited by 101
Botta, C., Barbieri, V., Ciliberto, D., Rossi, A., Rocco, D., Addeo, R., Staropoli, N., Pastina, P., Marvaso, G., Martellucci, I., et al. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.24425 · Cited by 92
Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism
Yang, F., Lee, G., & Fan, Y. (2024) · Angiogenesis · doi:10.1007/s10456-024-09913-z · Cited by 94
Intravasation as a Key Step in Cancer Metastasis
Zavyalova, M. V., Denisov, E. V., Таширева, Л. А., Savelieva, O. E., Кайгородова, Е. В., Krakhmal, N. V., & Михайлович, П. В. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919070071 · Cited by 99
Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy
Lanitis, E., Irving, M. B., & Coukos, G. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01187-w · Cited by 95
The Vascular Microenvironment in Glioblastoma: A Comprehensive Review
Mosteiro, A., Pedrosa, L., Ferrés, A., Diao, D., Sierra, À., & González, J. J. (2022) · Biomedicines · doi:10.3390/biomedicines10061285 · Cited by 94
Schouppe, E., BAETSELIER, P. D., Ginderachter, J. A. V., & Sarukhan, A. (2012) · OncoImmunology · doi:10.4161/onci.21566 · Cited by 92
Forget, M. A., Voorhees, J. L., Cole, S. L., Dakhlallah, D., Patterson, I. L., Gross, A. C., Moldovan, L., Mo, X., Evans, R., Marsh, C. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098623 · Cited by 77
RetractedMacrophages in homeostatic immune function
Jantsch, J., Binger, K. J., Müller, D. N., & Titze, J. M. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00146 · Cited by 89
The Multifaceted Role of Perivascular Macrophages in Tumors
Lewis, C. E., Harney, A. S., & Pollard, J. W. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.07.009 · Cited by 85
Self-citationLin, Y., Tan, C., Chen, C.-W., Ou, D., Cheng, A., & Hsu, C. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1673621 · Cited by 84
Angiopoietin-2 in white adipose tissue improves metabolic homeostasis through enhanced angiogenesis
An, Y. A., Sun, K., Joffin, N., Zhang, F., Deng, Y., Donzé, O., Kusminski, C. M., & Scherer, P. E. (2017) · eLife · doi:10.7554/elife.24071 · Cited by 75
Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment
Chen, W., Shen, L., Jiang, J., Zhang, L., Zhang, Z., Pan, J., Ni, C., & Chen, Z. (2021) · Biomarker Research · doi:10.1186/s40364-021-00312-w · Cited by 79
Leveraging the immune system to treat advanced thyroid cancers
French, J. D., Bible, K. C., Spitzweg, C., Haugen, B. R., & Ryder, M. M. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30277-7 · Cited by 81
Macrophages promote the progression of premalignant mammary lesions to invasive cancer
Carron, E. C., Homra, S., Rosenberg, J. N., Coffelt, S. B., Kittrell, F. S., Zhang, Y., Creighton, C. J., Fuqua, S. A. W., Medina, D., & Machado, H. L. (2017) · Oncotarget · doi:10.18632/oncotarget.14913 · Cited by 76
Self-citationShklovskaya, E., & Rizos, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197139 · Cited by 73
The biology of vascular calcification
Quaglino, D., Boraldi, F., & Lofaro, F. D. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.02.007 · Cited by 73
Role of Angiopoietins in Development of Cancer and Neoplasia Associated with Viral Infection
Yu, X., & Ye, F. (2020) · Cells · doi:10.3390/cells9020457 · Cited by 68
Camelliti, S., Noci, V. L., Bianchi, F., Moscheni, C., Arnaboldi, F., Gagliano, N., Balsari, A., Garassino, M. C., Tagliabue, E., Sfondrini, L., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01721-9 · Cited by 68
Wu, F. T. H., Man, S., Xu, P., Chow, A., Paez-Ribes, M., Lee, C. R., Pirie-Shepherd, S. R., Emmenegger, U., & Kerbel, R. S. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0888 · Cited by 58
“, by blocking immunosuppressive Tie2-expressing monocytes (45, 46).”
BackgroundGarcía, S., Krausz, S., Ambarus, C. A., Fernández, B. M., Hartkamp, L. M., van Es, I. E., Hamann, J., Baeten, D. L., Tak, P. P., & Reedquist, K. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0082088 · Cited by 55
New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma
Mossenta, M., Busato, D., Baboçi, L., Cintio, F. D., Toffoli, G., & Bo, M. D. (2019) · Cancers · doi:10.3390/cancers11081086 · Cited by 56
Tumor Vessel Normalization: A Window to Enhancing Cancer Immunotherapy
Li, S., Zhang, Q., & Hong, Y. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820980116 · Cited by 54
Joseph, E. L. M., Laheurte, C., Jary, M., Boullerot, L., Asgarov, K., Gravelin, E., Bouard, A., Rangan, L., Dosset, M., Borg, C., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0326 · Cited by 55
Cortes, J. E., Talpaz, M., Smith, H. P., Snyder, D., Khoury, J., Bhalla, K. N., Pinilla-Ibarz, J. A., Larson, R. A., Mitchell, D., Wise, S., et al. (2016) · Haematologica · doi:10.3324/haematol.2016.152710 · Cited by 55
Peripheral loss of EphA4 ameliorates TBI-induced neuroinflammation and tissue damage
Kowalski, E., Chen, J., Hazy, A., Fritsch, L. E., Basso, E. K. G., Chen, M., Wang, X., Qian, Y., Zhou, M., Byerly, M., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1605-2 · Cited by 54
Boucher, Y., Kumar, A. S., Posada, J. M., Gjini, E., Pfaff, K. L., Lipschitz, M., Lako, A., Duda, D. G., Rodig, S. J., Hodi, F. S., et al. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00197-w · Cited by 53
Krausz, S., García, S., Ambarus, C. A., de Launay, D., Foster, M. L., Naiman, B. M., Iverson, W., Connor, J. R., Sleeman, M. A., Coyle, A. J., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200718 · Cited by 57
Bridging angiogenesis and immune evasion in the hypoxic tumor microenvironment
Schito, L. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00209.2018 · Cited by 52
Immune alterations and emerging immunotherapeutic approaches in lung cancer
Dasanu, C. A., Sethi, N., & Ahmed, N. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.685715 · Cited by 59
Guo, Z., Wen, Z., Qin, A., Zhou, Y., Liao, Z., Liu, Z., Liang, Y., Ren, T., & Xu, L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203233 · Cited by 52
Hypoxia: Turning vessels into vassals of cancer immunotolerance
Schito, L., & Rey, S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.015 · Cited by 49
Chatterjee, S., Das, S., Chakraborty, P., Manna, A., Chatterjee, M., & Choudhuri, S. K. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.08.271 · Cited by 49
More than a scaffold: Stromal modulation of tumor immunity
Johansson, A., Hamzah, J., & Ganß, R. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.06.001 · Cited by 49
Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy
Huang, Y., Fan, H., & Ti, H. (2024) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2024.100902 · Cited by 54
Ibberson, M. R., Bron, S., Guex, N., Hull, E. F.-V., Ifticene‐Treboux, A., Henry, L., Lehr, H., Delaloye, J.-F., Coukos, G., Xénarios, I., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3181 · Cited by 47
Asija, S., Chatterjee, A., Yadav, S., Chekuri, G., Karulkar, A., Jaiswal, A. K., Goda, J. S., & Purwar, R. (2022) · International Reviews of Immunology · doi:10.1080/08830185.2022.2101647 · Cited by 46
Liao, R., Jiang, N., Tang, Z.-W., Li, D.-W., Huang, P., Luo, S., Gong, J., & Du, C. (2016) · Oncotarget · doi:10.18632/oncotarget.9049 · Cited by 46
Telli, T. A., Bregni, G., Vanhooren, M., Saúde-Conde, R., Hendlisz, A., & Sclafani, F. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102460 · Cited by 46
Vasculotide reduces pulmonary hyperpermeability in experimental pneumococcal pneumonia
Gutbier, B., Jiang, X., Dietert, K., Ehrler, C., Lienau, J., Slyke, P. V., Kim, H. L., Hoang, V. C., Maynes, J. T., Dumont, D., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1851-6 · Cited by 44
Zhang, X., Ji, J., Zhang, G., Fang, C., Jiang, F., Ma, S., & Hou, J. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s147041 · Cited by 43
Maffei, R., Fiorcari, S., Bulgarelli, J., Martinelli, S., Castelli, I., Deaglio, S., Debbia, G., Fontana, M. C., Coluccio, V., Bonacorsi, G., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.054924 · Cited by 41
Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas
Cortes‐Santiago, N., Hossain, M. B., Gabrusiewicz, K. R., Fan, X., Gumin, J., Marini, F. C., Alonso, M. M., Lang, F. F., Yung, W. K. A., Fueyo-Margareto, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7550 · Cited by 42
Metadata
- Authors
- Coffelt, S. B., Chen, Y.-Y., Muthana, M., Welford, A. F., Tal, A. O., Scholz, A., Plate, K. H., Reiss, Y., Murdoch, C., De Palma, M., & Lewis, C. E.
- Affiliations
- University of Sheffield (GB)
- Goethe University Frankfurt (DE)
- Angiogenesis and Tumor Targeting Research Unit, San Raffaele-Telethon Institute for Gene Therapy, San Raffaele Scientific Institute , 20132 Milan ,
- Corresponding author
- Muthana, Munitta
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-04-01
- Volume
- 186
- Issue
- 7
- Pages
- 4183-4190
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2157483153
- Cited by
- 220
- References
- 32
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 14 · 2023: 15 · 2022: 17 · 2021: 17 · 2020: 23 · 2019: 20 · 2018: 13 · 2017: 8 · 2016: 19 · 2015: 10 · 2014: 13 · 2013: 14 · 2012: 14
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- Breast Cancer Campaign
- Deutsche Forschungsgemeinschaft (project C1), SFB‐TR23)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- angiopoietin-2, Tie2-expressing monocytes, regulatory T cells, T cell activation suppression, tumor immunosuppression, IL-10, CCL17, tumor angiogenesis, myeloid cells, CD4/CD8 ratio, Foxp3, tumor-associated macrophages
- MeSH terms
- Animals, Cell Differentiation, DNA-Binding Proteins, Growth Inhibitors, Humans, Lymphocyte Activation, Macrophages, Mammary Neoplasms, Experimental, Mice, Inbred BALB C, Mice, Transgenic, Monocytes, Neovascularization, Pathologic, Repressor Proteins, Transcription Factors, Interleukin-10, Cell Cycle Proteins, Carcinoma, Lewis Lung, Coculture Techniques, Angiopoietin-2, Cell Line, Tumor, T-Lymphocytes, Regulatory, Apoptosis Regulatory Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.